A detailed history of Jennison Associates LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Jennison Associates LLC holds 4,241,255 shares of BMY stock, worth $245 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
4,241,255
Previous 815,466 420.1%
Holding current value
$245 Million
Previous $33.9 Million 548.1%
% of portfolio
0.14%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$39.66 - $51.75 $136 Million - $177 Million
3,425,789 Added 420.1%
4,241,255 $219 Million
Q2 2024

Aug 05, 2024

SELL
$40.25 - $52.99 $10.1 Million - $13.3 Million
-250,449 Reduced 23.5%
815,466 $33.9 Million
Q1 2024

May 02, 2024

SELL
$47.98 - $54.4 $15.7 Million - $17.8 Million
-327,639 Reduced 23.51%
1,065,915 $57.8 Million
Q4 2023

Feb 01, 2024

SELL
$48.48 - $57.85 $115 Million - $137 Million
-2,375,382 Reduced 63.03%
1,393,554 $71.5 Million
Q3 2023

Oct 31, 2023

BUY
$57.89 - $64.73 $41.5 Million - $46.4 Million
716,218 Added 23.46%
3,768,936 $219 Million
Q2 2023

Aug 03, 2023

SELL
$63.71 - $70.74 $11.3 Million - $12.5 Million
-176,823 Reduced 5.48%
3,052,718 $195 Million
Q1 2023

Apr 26, 2023

SELL
$65.71 - $74.53 $10.7 Million - $12.2 Million
-163,385 Reduced 4.82%
3,229,541 $224 Million
Q4 2022

Feb 09, 2023

SELL
$68.48 - $81.09 $32.3 Million - $38.3 Million
-472,264 Reduced 12.22%
3,392,926 $244 Million
Q3 2022

Nov 01, 2022

SELL
$0.13 - $76.84 $29,913 - $17.7 Million
-230,101 Reduced 5.62%
3,865,190 $275 Million
Q2 2022

Aug 02, 2022

SELL
$72.62 - $79.98 $96.5 Million - $106 Million
-1,329,494 Reduced 24.51%
4,095,291 $315 Million
Q1 2022

May 11, 2022

BUY
$61.48 - $73.72 $117 Million - $140 Million
1,904,959 Added 54.12%
5,424,785 $396 Million
Q4 2021

Feb 08, 2022

BUY
$53.63 - $62.52 $91.8 Million - $107 Million
1,711,339 Added 94.63%
3,519,826 $219 Million
Q3 2021

Nov 09, 2021

SELL
$59.17 - $69.31 $1.62 Million - $1.9 Million
-27,443 Reduced 1.49%
1,808,487 $107 Million
Q2 2021

Aug 12, 2021

BUY
$61.91 - $67.42 $21.1 Million - $23 Million
340,428 Added 22.76%
1,835,930 $123 Million
Q1 2021

May 11, 2021

SELL
$59.34 - $66.74 $20.3 Million - $22.9 Million
-342,537 Reduced 18.64%
1,495,502 $94.4 Million
Q4 2020

Feb 05, 2021

BUY
$57.74 - $65.43 $5.61 Million - $6.36 Million
97,164 Added 5.58%
1,838,039 $114 Million
Q3 2020

Nov 04, 2020

BUY
$57.43 - $63.64 $2.51 Million - $2.78 Million
43,711 Added 2.58%
1,740,875 $105 Million
Q2 2020

Aug 06, 2020

BUY
$54.82 - $64.09 $26.5 Million - $31 Million
483,423 Added 39.83%
1,697,164 $99.8 Million
Q1 2020

May 06, 2020

BUY
$46.4 - $67.43 $28.9 Million - $42 Million
622,193 Added 105.18%
1,213,741 $67.7 Million
Q4 2019

Feb 07, 2020

SELL
$49.21 - $64.19 $9.5 Million - $12.4 Million
-193,114 Reduced 24.61%
591,548 $38 Million
Q3 2019

Nov 08, 2019

SELL
$42.77 - $50.71 $5.26 Million - $6.24 Million
-122,998 Reduced 13.55%
784,662 $39.8 Million
Q2 2019

Aug 06, 2019

SELL
$44.62 - $49.34 $521 Million - $576 Million
-11,666,690 Reduced 92.78%
907,660 $0
Q1 2019

May 10, 2019

BUY
$45.12 - $53.8 $64.7 Million - $77.1 Million
1,433,857 Added 12.87%
12,574,350 $600 Million
Q4 2018

Feb 06, 2019

SELL
$48.76 - $63.23 $506 Million - $657 Million
-10,386,066 Reduced 48.25%
11,140,493 $579 Million
Q3 2018

Nov 08, 2018

BUY
$55.19 - $62.25 $225 Million - $254 Million
4,080,245 Added 23.39%
21,526,559 $1.34 Billion
Q2 2018

Aug 02, 2018

SELL
$50.53 - $62.98 $446 Million - $556 Million
-8,827,109 Reduced 33.6%
17,446,314 $965 Million
Q1 2018

Apr 20, 2018

BUY
$59.92 - $68.98 $102 Million - $117 Million
1,699,455 Added 6.92%
26,273,423 $1.66 Billion
Q4 2017

Jan 25, 2018

SELL
$59.94 - $65.35 $137 Million - $149 Million
-2,280,274 Reduced 8.49%
24,573,968 $1.51 Billion
Q3 2017

Nov 03, 2017

BUY
$55.23 - $63.74 $1.48 Billion - $1.71 Billion
26,854,242
26,854,242 $1.71 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Jennison Associates LLC Portfolio

Follow Jennison Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.